[1]
Cooper, L.D. 2014. Value-Add: An Empirical Study of Idiosyncratic Value in the 2013 Biotech IPO Market. Columbia Business Law Review. 2014, 2 (Aug. 2014), 512–547. DOI:https://doi.org/10.7916/cblr.v2014i2.1778.